Tech Company Financing Transactions

Serenex Funding Round

Intersouth Partners, Lilly Ventures and Mediphase Venture Partners participated in a $31 million Series D venture round for Serenex. The financing round was announced on 6/28/2007.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series D
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Acquired or Merged
Mailing Address
323 Foster Street
Durham, NC 27701
Email Address
Not Recorded
Serenex is an integrated oncology-focused drug discovery and development company. The company's mission is to improve the lives of cancer patients by developing proprietary therapeutic and supportive care products.
Serenex LinkedIn Company Profile
Social Media
Serenex Company Twitter Account
Company News
Serenex News
Serenex on Facebook
Serenex on YouTube

Management Team

Email & Social
Chief Executive Officer
Richard Kent
  Richard Kent LinkedIn Profile  Richard Kent Twitter Account  Richard Kent News  Richard Kent on Facebook
Chief Financial Officer
Ian Howes
  Ian Howes LinkedIn Profile  Ian Howes Twitter Account  Ian Howes News  Ian Howes on Facebook
Vice President
Judy Bryson
  Judy Bryson LinkedIn Profile  Judy Bryson Twitter Account  Judy Bryson News  Judy Bryson on Facebook
Vice President
Alexander Smith
  Alexander Smith LinkedIn Profile  Alexander Smith Twitter Account  Alexander Smith News  Alexander Smith on Facebook
VP - Bus. Development
Anil Goyal
  Anil Goyal LinkedIn Profile  Anil Goyal Twitter Account  Anil Goyal News  Anil Goyal on Facebook
VP - Operations
George Young
  George Young LinkedIn Profile  George Young Twitter Account  George Young News  George Young on Facebook
VP - R & D
Steven Hall
  Steven Hall LinkedIn Profile  Steven Hall Twitter Account  Steven Hall News  Steven Hall on Facebook



Browse more venture capital transactions:

Prev: 6/28/2007: venture capital transaction
Next: 6/28/2007: ONI Medical Systems venture capital transaction


Share this article


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary